Similar articles for PMID: 17868016

Year	Number of Results
1957	1
1958	1
1959	1
1961	1
1977	1
1996	1
1997	1
1998	4
1999	2
2000	8
2001	1
2002	3
2004	2
2005	4
2006	9
2007	17
2008	23
2009	11
2010	3
2011	1
2012	4
2013	2
2014	1
2015	1
2016	2
2017	1
2020	1
2022	1
2024	0

1

Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.

Niino M, Fukazawa T, Kikuchi S, Sasaki H. Niino M, et al. Expert Rev Neurother. 2007 Sep;7(9):1175-88. doi: 10.1586/14737175.7.9.1175. Expert Rev Neurother. 2007. PMID: 17868016 Review.

2

The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.

Bahreini SA, Jabalameli MR, Saadatnia M, Zahednasab H. Bahreini SA, et al. J Neuroimmunol. 2010 Dec 15;229(1-2):5-15. doi: 10.1016/j.jneuroim.2010.08.002. Epub 2010 Sep 15. J Neuroimmunol. 2010. PMID: 20832869 Review.

3

Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.

Camiña-Tato M, Morcillo-Suárez C, Navarro A, Fernández M, Horga A, Montalban X, Comabella M. Camiña-Tato M, et al. J Neuroimmunol. 2009 Aug 18;213(1-2):142-7. doi: 10.1016/j.jneuroim.2009.05.010. Epub 2009 Jun 9. J Neuroimmunol. 2009. PMID: 19515430

4

SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.

Burfoot RK, Jensen CJ, Field J, Stankovich J, Varney MD, Johnson LJ, Butzkueven H, Booth D, Bahlo M, Tait BD, Taylor BV, Speed TP, Heard R, Stewart GJ, Foote SJ, Kilpatrick TJ, Rubio JP. Burfoot RK, et al. Tissue Antigens. 2008 Jan;71(1):42-50. doi: 10.1111/j.1399-0039.2007.00962.x. Epub 2007 Oct 30. Tissue Antigens. 2008. PMID: 17971048

5

EVI5 is a risk gene for multiple sclerosis.

Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, van Duijn CM, Hintzen RQ. Hoppenbrouwers IA, et al. Genes Immun. 2008 Jun;9(4):334-7. doi: 10.1038/gene.2008.22. Epub 2008 Apr 10. Genes Immun. 2008. PMID: 18401352

6

Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.

Perera D, Stankovich J, Butzkueven H, Taylor BV, Foote SJ, Kilpatrick TJ, Rubio JP. Perera D, et al. J Neuroimmunol. 2009 Jun 25;211(1-2):105-9. doi: 10.1016/j.jneuroim.2009.03.010. Epub 2009 Apr 17. J Neuroimmunol. 2009. PMID: 19375175

7

[Genetic susceptibility to multiple sclerosis (MS). INSERM Network of Clinical Research on the Genetic Susceptibility to MS].

Fontaine B. Fontaine B. Rev Neurol (Paris). 1998 Sep;154(8-9):601-5. Rev Neurol (Paris). 1998. PMID: 9809375 Review. French.

8

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

Byun E, Caillier SJ, Montalban X, Villoslada P, Fernández O, Brassat D, Comabella M, Wang J, Barcellos LF, Baranzini SE, Oksenberg JR. Byun E, et al. Arch Neurol. 2008 Mar;65(3):337-44. doi: 10.1001/archneurol.2008.47. Epub 2008 Jan 14. Arch Neurol. 2008. PMID: 18195134 Clinical Trial.

9

Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.

Márquez A, Cénit MC, Núñez C, Mendoza JL, Taxonera C, Díaz-Rubio M, Bartolomé M, Arroyo R, Fernández-Arquero M, de la Concha EG, Urcelay E. Márquez A, et al. Genes Immun. 2009 Oct;10(7):631-5. doi: 10.1038/gene.2009.56. Epub 2009 Aug 6. Genes Immun. 2009. PMID: 19657358

10

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.

Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. Oksenberg JR, et al. Nat Rev Genet. 2008 Jul;9(7):516-26. doi: 10.1038/nrg2395. Epub 2008 Jun 10. Nat Rev Genet. 2008. PMID: 18542080 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year